Microglial PGC-1α protects against ischemic brain injury by suppressing neuroinflammation.

Mechanistically, in AIS, PGC-1α promotes autophagy and mitophagy through ULK1 and reduces NLRP3 activation. Our findings indicate that microglial PGC-1α may be a promising therapeutic target for AIS.